Shaping the Future of Medicine Together
Be part of a global team dedicated to accelerating the development and commercialization of advanced therapies that transform lives.

A New Chapter in Advanced Therapies
We are excited to share that Altaris completed its acquisition of Advanced Therapies U.S. and OXGENE (together “Advanced Therapies”) on 7 March 2025.
Advanced Therapies is now fully owned by Altaris and headquartered in the United States.
As we continue to expand, we remain committed to developing life-changing therapies and building a world-class team.
If you’re interested in career opportunities with us, please complete the form on this page to receive a link to our current job listings.